Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | CPA1 | P15085 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250458 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL30552195 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL21417705 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL24932734 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL10062994 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL1319707 | 0.83 | SMN1; SMN2 (0.44) | ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL1319709 | 0.83 | SMN1; SMN2 (0.44) | ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL16640683 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL12301656 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL14374026 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115656161-A | Phthalic dicarboxaldehyde disinfectant concentration detection indicator card and preparation method thereof | 利康医药科技江苏有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| US-12064459-B2 | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | DERMBIONT, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20240182532-A1 | MICROPEPTIDES AND USES THEREOF | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-06-06 | — | — | US | disclosed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-115991938-B | Polyphosphazene polymer hydrogel and preparation method and application thereof | 深圳市罗湖区中医院 | 2024-03-15 | — | — | CN | disclosed |
| US-11858972-B2 | Micropeptides and uses thereof | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-01-02 | — | — | US | disclosed |
| CN-115991938-A | Polyphosphazene polymer hydrogel and preparation method and application thereof | 深圳市罗湖区中医院 | 2023-04-21 | — | — | CN | disclosed |
| EP-4107166-A1 | HETEROARYL COMPOUNDS FOR TREATMENT OF COMPLEMENT FACTOR D MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2022-12-28 | — | — | EP | disclosed |
| US-20220120732-A1 | TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-04-21 | — | — | US | disclosed |
| US-20090242879-A1 | Optoelectronic device and method of fabricating the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-10-01 | — | — | US | disclosed |
| US-7524929-B2 | polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-04-28 | — | — | US | disclosed |
| EP-1677816-A4 | THERAPEUTIC METHOD | UNIV MONASH (AU) | 2009-04-22 | — | — | EP | disclosed |
| WO-2009042892-A1 | CYCLIC UNDECAPEPTIDES AND DERIVATIVES AS MULTIPLE SCLEROSIS THERAPIES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2009-04-02 | — | — | WO | disclosed |
| US-20080305471-A1 | polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-12-11 | — | — | US | disclosed |
| CN-101084005-A | Compounds for flaviviridae treatment | NOVARTIS AG (CH) | 2007-12-05 | — | — | CN | disclosed |
| EP-1677816-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005032578-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2005-04-14 | — | — | WO | disclosed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | disclosed |